Immunic says it’s on track to announce early data by year’s end from twin late-stage trials testing vidofludimus calcium (IMU-838) — an oral therapy believed to have both anti-inflammatory and neuroprotective properties — in people with relapsing forms of multiple sclerosis (MS). The top-line results from the…
Discussion
A trio of scientists in Australia has developed a mathematical model that can be used to help understand disease activity patterns in people with multiple sclerosis (MS). The model uses two overarching variables — inflammation and myelin damage — to describe how relapses and stable disease occur in…
Discussion
A drug used to prevent stroke complications may help preserve myelin, the protective coating around nerve fibers that is damaged in multiple sclerosis (MS), according to a review of data from animal studies. The treatment, nimodipine, was also associated with reduced inflammation, nerve damage, and disease severity in several…
Discussion
People with relapsing-remitting multiple sclerosis (RRMS) who show even a single silent lesion on an MRI scan while taking a lower- or moderate-efficacy disease-modifying therapy (DMT) may benefit from switching to a higher-efficacy treatment, according to a large international study. Researchers found that having one or more silent…
Discussion
I’m drowning. Well, not literally. I’ve never even come close to actually drowning — not even with last year’s pneumonia and the occasional aspiration of liquids. I’m just using it as a metaphor because it seems fitting and I know how much everyone likes metaphors. It may be a…
Get regular updates to your inbox.
